Compounders Research Compare

NeuroSense Therapeutics Ltd.(NRSN)

Biotechnology · Herzliya, TA

$3.95-0.08 (-1.99%)

Delayed quote: Oct 6, 2026, 11:58 AM EDT

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.

Herzliya, TA

17 employees

www.neurosense-tx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alon Ben-Noon

View full financials

NeuroSense Therapeutics (NRSN) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:04:18.277Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:04:18.277Z.

Quote observation: 2026-10-06T15:58:41.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2025-12-31: -8.908
Quote price: 3.95

FMP input reference: 7269c43ec051f04bc9b25698fa87f96476c1bd81d443a59abbb4ab2a9593cf8e

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

NRSN Earnings Yield Metrics

EARNINGS YIELD

N/A

NRSN Competitors' Earnings Yield

NeuroSense Therapeutics Ltd.

Current

Market Cap

$6.98M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Mangoceuticals, Inc.

Market Cap

$6.98M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Bolt Biotherapeutics, Inc.

Market Cap

$6.99M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KALA BIO, Inc.

Market Cap

$7.16M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Co-Diagnostics, Inc.

Market Cap

$6.69M

Earnings Yield

N/A

TTM Avg

21.79%

3Y Avg

16.65%

5Y Avg

16.65%

Curanex Pharmaceuticals Inc Common Stock

Market Cap

$7.23M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

InMed Pharmaceuticals Inc.

Market Cap

$7.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Longeveron Inc.

Market Cap

$7.27M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aclarion, Inc.

Market Cap

$6.66M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNS Pharmaceuticals, Inc.

Market Cap

$7.29M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
NeuroSense Therapeutics Ltd. (NRSN)	$6.98M	N/A	N/A	N/A	N/A
Mangoceuticals, Inc. (MGRX)vs ›	$6.98M	N/A	N/A	N/A	N/A
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.99M	N/A	N/A	N/A	N/A
KALA BIO, Inc. (KALA)vs ›	$7.16M	N/A	N/A	N/A	N/A
Co-Diagnostics, Inc. (CODX)vs ›	$6.69M	N/A	21.79%	16.65%	16.65%
Curanex Pharmaceuticals Inc Common Stock (CURX)vs ›	$7.23M	N/A	N/A	N/A	N/A
InMed Pharmaceuticals Inc. (INM)vs ›	$7.25M	N/A	N/A	N/A	N/A
Longeveron Inc. (LGVN)vs ›	$7.27M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.66M	N/A	N/A	N/A	N/A
CNS Pharmaceuticals, Inc. (CNSP)vs ›	$7.29M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics